Dermatology Update

Arcutis Canada Inc.

Arcutis Canada Inc.

2 sessions, November 13–14

Arcutis Canada, Inc. is a wholly owned subsidiary of Arcutis Biotherapeutics. Arcutis Biotherapeutics champions innovation that addresses unmet patient needs—solving the everyday medical dermatology challenges that significantly impact patients and their families. With a passion for understanding what really matters to patients and healthcare providers, Arcutis leverages extensive dermatology development expertise to meaningfully advance the treatment of immune-mediated skin diseases.

This expertise, along with Arcutis’ focus on biologically validated targets and its unique dermatology drug development platform prepares the company to tackle topical treatment innovation. Arcutis’ robust pipeline includes multiple development programs for a range of inflammatory dermatological conditions.
Visit arcutis.ca or follow Arcutis on LinkedIn and Twitter.

With the belief that patients deserve better than the current standard of care, the Arcutis team brings a sense of urgency, simplifying disease management and optimizing drug efficacy, safety, and tolerability to meet the needs of healthcare providers and patients.

Sessions at Dermatology Update — Fall 2026

2 sessions